• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

是否进行眶内容剜除术:埃及一家三级眼科护理中心在新冠疫情时代针对毛霉菌病提出的一种简单管理算法

Exenterate or Not: A Simple Proposed Management Algorithm for Mucormycosis During the Era of COVID-19 in a Tertiary Eye Care Center in Egypt.

作者信息

Shabana Reham Refaat, Eldesouky Mohamed Ashraf, Elbedewy Hazem A

机构信息

Department of Ophthalmology, Faculty of Medicine, Tanta University, Tanta, Gharbeya, Egypt.

出版信息

Clin Ophthalmol. 2022 Jun 11;16:1933-1940. doi: 10.2147/OPTH.S366067. eCollection 2022.

DOI:10.2147/OPTH.S366067
PMID:35720737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9199953/
Abstract

PURPOSE

To construct a simple management algorithm for cases with orbital mucormycosis during the COVID-19 era.

METHODS

Retrospective study included records of 30 Egyptian patients with post COVID-19 orbital mucormycosis. They underwent full clinical examination, laboratory investigations, Computed tomography (CT)/magnetic resonance imaging (MRI) of the paranasal sinuses and pathological specimen examination. The proposed algorithm was based on all the available data of the included patients.

RESULTS

The mean age of the studied patients was 62.47±11.13 years; 56.6% were females and 63.3% had uncontrolled diabetes mellitus. The main presentation was Orbital apex syndrome (OAS) in 43.3% of the cases. Twenty-six patients (86.6%) received systemic liposomal amphotericin B, while 4 patients (13.3%) received posaconazole. Orbital exenteration was done in 6 patients (20.0%), 4 of them died (66.7%). Twenty-four patients (80%) survived with clinical but not with visual improvement.

CONCLUSION

Systemic antifungal treatment and functional endoscopic sinus surgery (FESS) with extensive debridement of involved necrotic tissues were the main steps to control ROCM. Orbital exenteration should be kept for cases with periorbital tissue affection as it did not increase the final cure rate. The proposed management algorithm is supposed to be simple and easy to follow.

摘要

目的

构建一种适用于新冠疫情时代眼眶毛霉菌病病例的简单管理算法。

方法

回顾性研究纳入了30例新冠后眼眶毛霉菌病埃及患者的记录。他们接受了全面的临床检查、实验室检查、鼻窦计算机断层扫描(CT)/磁共振成像(MRI)以及病理标本检查。所提出的算法基于纳入患者的所有可用数据。

结果

研究患者的平均年龄为62.47±11.13岁;56.6%为女性,63.3%患有未控制的糖尿病。主要表现为眼眶尖综合征(OAS),占病例的43.3%。26例患者(86.6%)接受了全身性脂质体两性霉素B治疗,而4例患者(13.3%)接受了泊沙康唑治疗。6例患者(20.0%)进行了眼眶内容物剜除术,其中4例死亡(66.7%)。24例患者(80%)存活,临床症状有所改善,但视力未改善。

结论

全身性抗真菌治疗以及功能性鼻内镜鼻窦手术(FESS)并广泛清除受累坏死组织是控制眼眶毛霉菌病的主要步骤。对于眶周组织受累的病例应保留眼眶内容物剜除术,因为它并未提高最终治愈率。所提出的管理算法应该简单且易于遵循。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d5/9199953/be2cfd17ecee/OPTH-16-1933-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d5/9199953/77789f9bbcc1/OPTH-16-1933-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d5/9199953/20f2aae84456/OPTH-16-1933-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d5/9199953/fd6cb7da80dd/OPTH-16-1933-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d5/9199953/be2cfd17ecee/OPTH-16-1933-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d5/9199953/77789f9bbcc1/OPTH-16-1933-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d5/9199953/20f2aae84456/OPTH-16-1933-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d5/9199953/fd6cb7da80dd/OPTH-16-1933-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d5/9199953/be2cfd17ecee/OPTH-16-1933-g0004.jpg

相似文献

1
Exenterate or Not: A Simple Proposed Management Algorithm for Mucormycosis During the Era of COVID-19 in a Tertiary Eye Care Center in Egypt.是否进行眶内容剜除术:埃及一家三级眼科护理中心在新冠疫情时代针对毛霉菌病提出的一种简单管理算法
Clin Ophthalmol. 2022 Jun 11;16:1933-1940. doi: 10.2147/OPTH.S366067. eCollection 2022.
2
A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.对11例最初表现为眶尖综合征的侵袭性鼻眶脑毛霉菌病病例进行回顾性分析。
BMC Ophthalmol. 2016 Jan 12;16:10. doi: 10.1186/s12886-016-0189-1.
3
Clinical outcome of orbital apex syndrome in COVID associated mucormycosis patients in a tertiary care hospital.一家三级医院中新冠相关毛霉菌病患者眼眶尖综合征的临床结局
Int J Ophthalmol. 2022 Apr 18;15(4):527-532. doi: 10.18240/ijo.2022.04.01. eCollection 2022.
4
Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.COVID-19患者毛霉菌病的临床病理研究:来自印度南部一家三级医疗中心的经验
Cureus. 2022 Mar 10;14(3):e23016. doi: 10.7759/cureus.23016. eCollection 2022 Mar.
5
Clinical profile, prognostic factors, and outcomes of rhino-orbital-cerebral mucormycosis in the setting of COVID-19: A retrospective study.2019冠状病毒病背景下鼻眶脑型毛霉病的临床特征、预后因素及结局:一项回顾性研究
Saudi J Ophthalmol. 2023 May 26;37(2):100-106. doi: 10.4103/sjopt.sjopt_155_22. eCollection 2023 Apr-Jun.
6
Functional Endoscopic Sinus Surgery and Recurrence of Post-COVID Mucormycosis.功能性鼻内镜鼻窦手术与新冠后毛霉菌病复发
J Maxillofac Oral Surg. 2022 Oct 11;23(5):1-8. doi: 10.1007/s12663-022-01810-6.
7
Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.眼眶内容剜除术:毛霉病伴眶尖综合征的一个难题。
Am J Rhinol. 2008 Jan-Feb;22(1):98-103. doi: 10.2500/ajr.2008.22.3121.
8
Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe.眼眶毛霉菌病:了解席卷全球的致命真菌。
Cureus. 2023 Jun 26;15(6):e41010. doi: 10.7759/cureus.41010. eCollection 2023 Jun.
9
COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients.新型冠状病毒肺炎相关鼻眶脑型毛霉菌病:一项对264例患者的单中心前瞻性研究
Orbit. 2025 Feb;44(1):24-33. doi: 10.1080/01676830.2024.2377249. Epub 2024 Jul 25.
10
Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.三级护理医院中新冠疫情第二波期间毛霉菌病概况研究
Cureus. 2022 Jan 9;14(1):e21054. doi: 10.7759/cureus.21054. eCollection 2022 Jan.

引用本文的文献

1
Fungal infections in patients after recovering from COVID-19: a systematic review.新冠病毒感染康复患者的真菌感染:一项系统综述
Ther Adv Infect Dis. 2024 May 4;11:20499361241242963. doi: 10.1177/20499361241242963. eCollection 2024 Jan-Dec.
2
Survival benefit of exenteration in COVID-19-associated rhino-orbital mucormycosis.在新型冠状病毒肺炎相关鼻眶毛霉菌病中,眼眶内容剜除术的生存获益情况。
Indian J Ophthalmol. 2024 Feb 1;72(2):190-194. doi: 10.4103/IJO.IJO_2543_22. Epub 2023 Dec 15.
3
Is low dose of liposomal amphotericin B effective in management of acute invasive fungal rhinosinusitis? Our conclusions from Al-Mowassat University Hospital, Syria: a prospective observational study.

本文引用的文献

1
Mucormycosis: time to address this deadly fungal infection.毛霉病:是时候应对这种致命的真菌感染了。
Lancet Microbe. 2021 Aug;2(8):e343-e344. doi: 10.1016/S2666-5247(21)00148-8. Epub 2021 Jun 14.
2
Characteristics and Outcomes of a Series of COVID-Associated Mucormycosis Patients in Two Different Settings in Egypt Through the Third Pandemic Wave.埃及第三波疫情期间,在两种不同环境下一系列新冠相关毛霉菌病患者的特征与结局
Clin Ophthalmol. 2021 Dec 22;15:4795-4800. doi: 10.2147/OPTH.S344937. eCollection 2021.
3
Role of medial orbital wall decompression in COVID-19-associated rhino-orbital mucormycosis management.
低剂量脂质体两性霉素 B 治疗急性侵袭性真菌性鼻-鼻窦炎是否有效?我们从叙利亚的 Al-Mowassat 大学医院得到的结论:一项前瞻性观察性研究。
BMC Infect Dis. 2023 Mar 31;23(1):196. doi: 10.1186/s12879-023-08177-0.
4
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review.新型冠状病毒肺炎相关毛霉菌病(CAM)的临床表型:一项综述
Diagnostics (Basel). 2022 Dec 8;12(12):3092. doi: 10.3390/diagnostics12123092.
5
Invasive Fungal Diseases in Africa: A Critical Literature Review.非洲的侵袭性真菌病:一项重要文献综述
J Fungi (Basel). 2022 Nov 22;8(12):1236. doi: 10.3390/jof8121236.
内侧眶壁减压术在新型冠状病毒肺炎相关鼻眶毛霉菌病治疗中的作用
Indian J Ophthalmol. 2021 Dec;69(12):3795-3796. doi: 10.4103/ijo.IJO_1294_21.
4
Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.2021 年 COVID-19 第三波期间的鼻-眶-脑毛霉菌病:来自一家三级医院的埃及初步报告。
Neurol Sci. 2022 Feb;43(2):799-809. doi: 10.1007/s10072-021-05740-y. Epub 2021 Nov 17.
5
Mucormycosis - An opportunistic infection in the aged immunocompromised individual: A reason for concern in COVID-19.毛霉菌病——老年免疫功能低下个体中的一种机会性感染:COVID-19中值得关注的一个原因。
Maturitas. 2021 Dec;154:58-61. doi: 10.1016/j.maturitas.2021.07.009. Epub 2021 Jul 22.
6
Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.新冠后 rhino-orbito-cerebral mucormycosis:大流行控制挑战的新挑战。
Eur Arch Otorhinolaryngol. 2022 May;279(5):2417-2422. doi: 10.1007/s00405-021-07010-1. Epub 2021 Jul 26.
7
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究(COSMIC),报告 1。
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
8
Spike in Rhino-Orbital-Cerebral Mucormycosis Cases Presenting to a Tertiary Care Center During the COVID-19 Pandemic.新型冠状病毒肺炎大流行期间,一家三级医疗中心收治的鼻眶脑毛霉菌病病例激增。
Front Med (Lausanne). 2021 May 28;8:645270. doi: 10.3389/fmed.2021.645270. eCollection 2021.
9
Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.不同临床表现的重症 COVID-19 患者对鼻眶脑毛霉菌真菌感染的易感性。
Jpn J Ophthalmol. 2021 Jul;65(4):515-525. doi: 10.1007/s10384-021-00845-5. Epub 2021 May 31.
10
Invasive Fungal Sinusitis in Post COVID-19 Patients: A New Clinical Entity.新冠病毒感染后侵袭性真菌性鼻窦炎:一种新的临床实体。
Laryngoscope. 2021 Dec;131(12):2652-2658. doi: 10.1002/lary.29632. Epub 2021 May 22.